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Background: Acute acalculous cholecystitis (AAC) is generally considered to be a mild disease
in children; however, if left untreated or treated without caution, AAC can lead to severe out-
comes, such as death. The objectives of this study were to present the clinical features and
identify the predictors of mortality in pediatric AAC.
Methods: Patients diagnosed with AAC between 2005 and 2012 were enrolled. AAC was defined
by the presence of fever and an echo-proven thickened gallbladder wall exceeding 4 mm. A
poor health outcome was defined as death. Further information related to the demographics,
clinical manifestations, laboratory results, ultrasound findings, and pathogens present in the
AAC patients was also collected. Predictors of mortality were identified by association analyses
and confirmed by multivariate logistic regression.
Results: A total of 147 pediatric AAC patients (male/female Z 1.01, mean age Z 5.2 years)
were included in this retrospective study. The most common clinical presentation was an
elevated C-reactive protein level (84%) followed by hepatomegaly (80%) and anorexia (78%).
AAC in children was associated with various diseases, including infectious diseases (70%), sys-
temic diseases (13%), and malignancy (11%). Fourteen of the 147 (9.25%) patients died during
the study period. The presences of thrombocytopenia, anemia, gallbladder sludge, hepatitis,
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and/or sepsis plus hepatitis were found to be the important predictors of AAC mortality.
Conclusions: The factors associated with AAC mortality were anemia, thrombocytopenia, gall-
bladder sludge, hepatitis, and sepsis plus hepatitis. These predictors are likely to help clini-
cians identify patients who are at a high risk of poor prognoses and make appropriate
clinical decisions.
Copyright ª 2017, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
1. Introduction
Acute cholecystitis, inflammation of the gallbladder, is
primarily caused by cholelithiasis in adults, and acute
acalculous cholecystitis (AAC) causes only 2e15% of acute
cholecystitis cases. However, among pediatric patients,
AAC usually appears as a complication of other diseases,
such as pneumonia, gastroenteritis, sepsis, and other sys-
temic diseases.1e5 AAC can also be found in patients with
critical conditions including chemotherapy, bone marrow
transplantation, immunosuppression, postsurgery symp-
toms, prolonged fasting, and major trauma.6e10
In adults, AAC can be treated with invasive procedures,
such as cholecystectomy and percutaneous chol-
ecystostomy. These harmless and low-risk surgeries should
be arranged while the disease is mild to prevent severe
complications and the recurrence of AAC.11,12 Otherwise,
approximately 40e100% of AAC patients may advance to
gallbladder gangrene, gallbladder perforation, or multi-
organ dysfunction. These advanced complications may
eventually lead to death in 30% of patients.12
In adults, although AAC can be treated with surgical pro-
cedures, such as cholecystectomy and percutaneous chol-
ecystostomy, for pediatric patients with AAC we primarily
choose conservative treatmentsfirst. There are few studies of
AACoperations in children. AAC can potentially lead to severe
complications and cause death if left untreated; however,
little is known about the predictors of these poor outcomes.
Thus, the purposes of this study were to investigate the
clinical manifestations, laboratory data, and pathogens
related toAAC in addition to exploring their relationshipswith
AAC-related death and identifying the important predictors
to help clinicians make informed decisions.
2. Methods
The current study was approved by the Institutional Review
Board of Chang Gung Memorial Hospital, Taiwan. All pedi-
atric patients who were admitted to Chang Gung Children’s
Hospital in Northern Taiwan because of AAC without sur-
gery, trauma, or burn injury from January 2005 to
December 2012 were reviewed. The criteria for enrollment
included the following: (1) fever (from the medical notes),
(2) thickening of the gallbladder wall exceeding 4 mm
based on abdominal ultrasound (from imaging reports), and
(3) clinical symptoms (at least one of the following:
abdominal pain, vomiting, and jaundice). Individuals with
congenital biliary tract abnormalities were excluded
because of different bile juice flows and a higher incidence
of cholecystitis.
The main outcomes of the current study were the in-
dicators of poor prognoses, which were defined as death.
The definition of AAC-related mortality was clarified as that
occurring within 7 days after AAC onset. Information asso-
ciated with the patients’ clinical manifestations (such as
fever duration, vital signs, and blood pressure), laboratory
data (such as coagulation and blood culture test results),
and the presence of pathogens (such as those identified by
viral DNA analysis and bacterial culture) was collected
retrospectively via the medical notes. Hepatitis was
defined by an alanine aminotransferase (ALT) level of more
than 200 U/L. The definition of sepsis was the presence of
the clinical signs of fever combined with a positive blood
culture finding. The analyzed abdominal ultrasound reports
were those taken 3 days after fever onset from the eligible
patients during hospitalization using a Siemens Acuson
Antares Premium Edition (Siemens Medical Solutions USA,
Inc., Mountain View, CA, USA) with a VFX 9-4 linear probe at
frequencies of 2.5e6.15 Hz.
Clinical information and laboratory data related to dis-
ease severity were also collected. According to the newly
developed severity grading system defined by the Tokyo
Guidelines Revision Committee in 2013, also known as the
TG13,13 the disease severity was classified into three cat-
egories: mild, moderate, and severe. This classification is
based on patients’ symptoms (duration, local inflammation,
and palpable right upper abdominal mass), laboratory data
(leukocytosis, thrombocytopenia, and coagulopathy), and
organ dysfunction (cardiovascular, neurological, renal, and
hepatic dysfunction). Severe disease was defined as a
condition in which the patient had developed organ
dysfunction, and intensive care, including respiratory and
circulatory management, was required. Moderate disease
was defined by the presence of acute inflammation symp-
toms, including an elevated white blood cell count, a
palpable tender mass over the right upper abdominal
quadrant, a duration of symptoms exceeding 3 days, and
marked local inflammation. Mild disease was defined by the
presence of disease that failed to meet the criteria for
moderate or severe disease.
Regarding the analyses, the patients’ baseline charac-
teristics and their clinical presentations were described
using standard statistical analyses. To examine the associ-
ations between the indicators of poor outcome and the
above-mentioned patient information, the chi-square test
was used for the categorical variables, and the t test was
used for the continuous variables. Finally, multivariate lo-
gistic regression with a stepwise procedure was used to
explore the predictors of mortality. All analyses were per-
formed using SAS version 9.2 statistical software (SAS 9.1
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edn; SAS Institute Inc., Cary, NC, USA). Two-sided p values
less than 0.05 were considered statistically significant.
3. Results
In total, 217 eligible pediatric patients were admitted to
Chang Gung Children’s Hospital over the 8-year study
period. After reviewing the charts, 149 patients were found
to meet the inclusion criteria (of having a history of fever).
However, two of them had gallstones revealed on sono-
gram, which left a total of 147 AAC patients who were
eligible for analyses.
The clinical features of the AAC patients are presented
in Table 1. The median age of the 147 AAC patients was
4 years with a range of 9 days to 18 years. The median
duration of fever was 4 days. Among these 147 AAC pa-
tients, 43 (29.25%) had been transferred to the intensive
care unit (ICU) because of severe illness, and 14 (9.52%) of
them unfortunately died. The laboratory results of the
patients with AAC are also provided in Table 1. The most
common abnormal laboratory sign was an elevated C-
reactive protein (CRP) level (83.67%) followed by liver
function impairment, which included abnormal aspartate
aminotransferase (AST, 69.39%) and ALT (62.59%) levels and
coagulopathy [international normalized ratio (INR) > 2,
34.69%].
The clinical manifestations and ultrasound findings of the
patients with AAC are listed in Table 2. As illustrated, the
most common clinical manifestation was fever (100%), fol-
lowed by anorexia (78.23%), jaundice (40.14%) and abdom-
inal pain (36.05%). However, notably, the number of
abdominal pain complaints might have been underestimated
owing to poor expression of this symptom by pediatric pa-
tients. Apart from gallbladder wall thickening, the following
image findings were most frequently observed: hepato-
megaly (79.59%), ascites (44.90%), and splenomegaly
(42.86%). Also, notably, up to 10.20% of the patients with
AAC had sludge in the gallbladder that was related to bile
stasis or influenced by a hemodynamic abnormality.
Several diseases and pathogens associated with AAC
were observed in children (Table 3). The common infec-
tious diseases associated with AAC were sepsis (14.98%),
hepatitis (14.29%), and pneumonia (12.24%). The common
viral pathogens found in the patients with AAC were Eps-
teineBarr virus (21.77%) and cytomegalovirus (CMV)
(6.80%), and the common bacterial pathogens were Strep-
tococcus (3.40%), Escherichia coli (2.72%), and Staphylo-
coccus (2.04%).
The association analyses revealed that several clinical
signs were associated with AAC death. The details can be
Table 1 Demographic and laboratory results of 147 pe-
diatric AAC patients.
Demographics and outcome
Age (y) 5.19  4.45 (median
age: 4 y)
Sex M:/F Z 74:73 (1.01)
Fever duration (d) 4.95 (median: 4 d,
range: 1e30 d)
Intensive care 43 (29.25%)
Mortality 14 (9.52%)
Laboratory values*
White blood cell
count (1000/mL)
11.77  8.22 (0.2e43.7)
Hemoglobin (g/dL) 11.14  2.01 (5.6e14.8)
Platelet count (1000/mL) 184.02  131.22 (4e574)
Prothrombin time (s) 17.14  8.22 (10.5e62.2)
Activated partial
thromboplastin time (s)
46.71  18.73 (23.2e112.7)
International
normalized ratio
1.76  1.00 (1e15.5)
C-reactive protein (mg/L) 83.40  94.19
(0.96e319.11)
Aspartate
aminotransferase (U/L)
571.32  1725.26
(11e15,892)
Alanine
aminotransferase (U/L)
365.91  713.87 (6e4807)
Blood urine
nitrogen (mg/dL)
13.87  14.82 (1.4e98)
Creatinine (mg/dL) 0.54  0.55 (0.1e4.97)
Direct form
bilirubin (mg/dL)
3.10  4.63 (0.1e31)
Total bilirubin (mg/dL) 4.93  6.48 (0.2e30.7)
r-glutamyl
transpeptidase (U/L)
182.39  201.65 (2e1211)
Alkaline
phosphatase (U/L)
394.69  540.76 (18e4192)
Albumin (g/dL) 3.18  0.73 (1.69e4.7)
ACC Z acute acalculous cholecystitis.
* The data are presented as mean  standard deviation
(minimumemaximum) unless otherwise indicated.
Table 2 Clinical manifestations and image findings
(n Z 147).
Clinical manifestations
Fever 147 (100)
Anorexia 115 (78.23)
Jaundice 59 (40.14)
Abdominal pain 53 (36.05)
Vomiting 48 (32.65)
Diarrhea 37 (25.17)
Neurologic symptoms* 19 (12.93)
Abdominal distention 9 (6.12)
Cardiovascular dysfunction 6 (4.08)
Gastrointestinal bleeding 2 (1.36)
Imaging findings
Gallbladder wall  4 mm 147 (100)
Hepatomegaly 117 (79.59)
Ascites 66 (44.90)
Splenomegaly 63 (42.86)
Gall sludge 15 (10.20)
Increased echogenicity
of general hepatic area
15 (10.20)
Increased echogenicity
of periportal area (biliary tree)
11 (7.48)
Enlarged intra-abdominal
lymph node
4 (2.72)
The data are presented as n (%).
* Including headache, seizure, drowsiness, confusion, and
dizziness.
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found in Table 4. Compared to the living patients, the pa-
tients who suffered mortality due to AAC seemed to be less
likely to have anorexia and more likely to have anemia, a
lower platelet count, a higher severity grading, impaired
liver function [including more coagulopathy and prolonged
activated partial thromboplastin time (APTT)], jaundice
(elevated total and direct bilirubin levels), bile sludge, and
sepsis plus hepatitis.
To further investigate the predictors of mortality in AAC,
a multivariate logistic regression was conducted, and the
results are presented in Table 5. As illustrated, factors such
as anemia (p Z 0.031), thrombocytopenia (p Z 0.046),
gallbladder sludge (p Z 0.017), hepatitis (p Z 0.018), and
sepsis plus hepatitis (p Z 0.005) were found to be signifi-
cant predictors of mortality in AAC patients. After adjust-
ments for other variables, patients with sepsis plus
hepatitis were 114 times more likely to die from AAC than
those without sepsis plus hepatitis.
4. Discussion
The current study aimed to identify the clinical signs (i.e.,
associated but not statistically significantly) and risk factors
(i.e., statistically significantly associated) related to AAC
death by examining all of the available clinical factors,
which included the patients’ clinical presentations, labo-
ratory results, and complications. Many factors were found
to be strongly associated with AAC death and could be
considered to be signs in clinical practice (Tables 2 and 3).
Some of these signs were further confirmed to be predictors
(such as platelet abnormalities and gallbladder sludge) via
regression analyses, and some of these signs were also in
line with those presented in the literature (e.g., infectious
diseases and severe illnesses14e21). In contrast, some of the
signs, such as CRP, hepatomegaly, and anorexia are thought
to be newly discovered and may become the predictors of
poor outcome in terms of increasing severity scores in the
future.
Although the sample size of this study is not extremely
large (n Z 147), it is sufficient to be considered represen-
tative of the general population based on the identical age
and sex distributions. The average age of the study popu-
lation was 5.2 years, and the median age was 4 years (Table
1). This distribution is in line with that of another published
study conducted in Taiwan in 2011 (mean
age Z 5.8 years)22 and slightly lower than those of other
relevant studies (mean ages ranging from 7.8 to
9.0 years).23,24 In terms of the sex ratio, no difference was
observed between the two groups (male/femaleZ 1.01:1).
This sex distribution is also in line with those of relevant
studies.22e24
AAC is related to many different diseases (Table 3). The
associated disease itself may not result in death but may
result in progression to mortality during the course of AAC.
In our study, five patients with oncological diseases and one
patient with systemic lupus erythematosus died. When the
associated diseases and risk factors are coincident, mor-
tality due to AAC increases. Therefore, we sought to be the
first to evaluate the different factors that predict poor
outcomes. Because different diseases are combined with
AAC, we could identify some risk factors that could guide
early intervention and prevent severe sequelae.
The main finding of the current study was the identifi-
cation of the risk factors for pediatric AAC death. A small
number of clinical signs were confirmed to be predictors in
the regression analyses (Table 5). A lower hemoglobin level,
a lower platelet count, gallbladder sludge, hepatitis, and
sepsis plus hepatitis were found to be five of such pre-
dictors. The associations of these predictors with AAC
death could be explained by the fact that all of them are
good surrogate measures for liver function, inflammation,
and infection.8 When liver function deteriorates and/or
infection occurs, the hemoglobin level and platelet count
decrease, and the patient is more likely to experience poor
and unfavorable health outcomes, such as death. Another
important factor for predicting poor outcomes is bile sludge
formation. The possible explanation is that the bile sludge
leads to low bile flow and consequently causes severe
inflammation that can lead to death. Finally, the key pre-
dictor that is worth mentioning is sepsis plus hepatitis.
Table 3 Clinical diseases and pathogens related to acute
acalculous cholecystitis (AAC; N Z 147).
Infectious diseases 103 (70.07)
Hepatitis 32 (21.77)
Sepsis (bacteremia and fungemia) 28 (19.05)
Pneumonia 18 (12.24)
Infectious mononucleosis 18 (12.24)
Acute gastroenteritis 13 (8.84)
Intra-abdominal infection 3 (2.04)
Urinary tract infection 2 (1.36)
Systemic diseases 20 (13.61)
Kawasaki disease 12 (8.17)
Systemic lupus erythematosus 4 (2.72)
Thalassemia 4 (2.72)
Malignancy 16 (10.88)
Hemophagocytic lymphohistiocytosis 7 (4.76)
Leukemia 5 (3.40)
Leukemia undergoing bone
marrow transplantation
4 (2.72)
Other* 8 (5.44)
Virus
EpsteineBarr virus 32 (21.77)
Cytomegalovirus 10 (6.80)
Mycoplasma 6 (4.08)
Influenza A virus 3 (2.04)
Othery 3 (2.04)
Bacteria
Streptococcus species 5 (3.40)
Escherichia coli 4 (2.72)
Staphylococcus species 3 (2.04)
Pseudomonas species 3 (2.04)
Salmonella species 2 (1.36)
Klebsiella species 2 (1.36)
Acinetobacter baumannii 2 (1.36)
Haemophilus influenzae 2 (1.36)
Yeast (Candida species) 3 (2.04)
Parasite (Plasmodium falciparum) 1 (0.68)
* Including drug induced, malaria, and idiopathic etiology.
y Including hepatitis A virus, hepatitis B virus, and herpes
simplex virus type I. The data are presented as n (%).
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Because of this deadly inflammatory situation, patients
with sepsis are prone to death (114 times more likely to
die). These findings are in line with those reported in the
relevant literature.25,26
Some predictors were found to lead to a worsening of
the disease course without leading to death, for example,
Streptococcus infection. Having a Streptococcus infection
increased the risk of requiring ICU care without increasing
the risk of death. A possible explanation for this finding is
that although Streptococcus infection can cause sepsis and
can introduce severe bacterial toxicity that could conse-
quently lead to ICU care, it can be cured with antibiotic
treatment, which prevents the worst health outcome, i.e.,
Table 5 Multivariate logistic analysis of association with
death.
Multivariate analysis
Coefficient p OR (95% CI)
Hemoglobin 0.37 0.031 0.69 (0.49e0.97)
Platelet count 0.01 0.046 0.99 (0.98e1.00)
Gallbladder sludge 1.01 0.017 0.13 (0.03e0.69)
Hepatitis 1.09 0.018 0.11 (0.02e0.69)
Sepsis plus hepatitis 1.62 0.005 0.04 (0.01e0.38)
CI Z confidence interval; OR Z odds ratio.
Table 4 Relative risk factors for an association with death.
Survival (n Z 133) Mortality (n Z 14) p
Clinical manifestation
Fever > 3 d 77 (57.89) 8 (57.14) 0.957
Fever > 7 d 20 (15.04) 2 (14.29) 0.94
Anorexia 108 (81.20) 7 (50.00) 0.007
Vomiting 42 (31.58) 6 (42.86) 0.392
Abdominal pain 49 (36.84) 4 (28.57) 0.771
Severity 0.015
Mild 28 (21.05) 1 (7.14) d
Moderate 55 (41.35) 2 (14.29) d
Severe 50 (37.60) 11 (78.57) d
Image
Hepatomegaly 108 (81.20) 9 (64.29) 0.162
Splenomegaly 59 (44.36) 4 (28.57) 0.395
Ascites 58 (43.61) 8 (57.14) 0.333
Gallbladder sludge 13 (9.77) 4 (28.57) 0.038
Gallbladder wall 4e7 mm 105 (78.95) 11 (78.57) 0.684
Gallbladder wall > 7 mm 28 (21.05) 3 (21.43) 0.684
Echogenicity 22 (16.54) 4 (28.57) 0.262
Laboratory
White blood cell (1000/mL) 12.23  8.27 7.48  6.53 0.039
Hemoglobin (g/dL) 11.31  1.89 9.54  2.52 0.002
Hematocrit (%) 34.26  7.36 28.66  8.04 0.008
Platelet (100/mL) 193.30  132.30 96.50  80.20 0.008
Prothrombin time (s) 16.21  7.98 21.49  8.26 0.034
Activated partial thromboplastin time (s) 44.27  18.18 56.11  18.45 0.034
International normalized ratio 1.72  1.94 1.94  0.74 0.679
C-reactive protein (mg/L) 82.07  95.46 95.53  83.98 0.613
Blood urine nitrogen (mg/dL) 12.96  14.41 20.43  16.78 0.102
Creatinine (mg/dL) 0.53  0.50 0.63  0.90 0.556
Aspartate aminotransferase (U/L) 563.60  1801.80 639.40  815.50 0.877
Alanine aminotransferase (U/L) 370.20  743.80 331.40  414.60 0.849
Direct form bilirubin (mg/dL) 2.38  4.22 7.80  4.60 <0.001
Total bilirubin (mg/dL) 3.57  4.57 14.42  9.61 <0.001
r-glutamyl transpeptidase (U/l) 193.90  213.80 122.50  108.80 0.309
Alkaline phosphatase (U/L) 330.30  258.90 716.90  1179.80 0.023
Albumin (g/dL) 3.25  0.72 2.81  0.71 0.038
Related diseases
Sepsis 21 (15.79) 7 (50) 1.000
Hepatitis 26 (19.55) 6 (42.86) 0.427
Sepsis plus hepatitis 2 (1.50) 3 (21.43) 0.040
Systemic lupus erythematosus 4 (3.01) 1 (7.14) 0.312
Streptococcus infection 5 (3.76) 0 (0) 0.984
The data are presented as n (%) or mean  the standard deviation.
Prognosis of childhood acute acalculous cholecystitis 501
death. Age is another example. Similar to Streptococcus
infection, a younger age could also increase the risk of
requiring ICU care but not the risk of death. Unlike Strep-
tococcus infection, a possible explanation for this finding is
that age might not be associated with AAC severity. How-
ever, the effects of the illness on the appearance of
younger patients might increase the chance of receiving
ICU care for precautionary reasons.
There are a small number of signs that were expected to
be predictors that could not be proven in the current study.
The first are the white blood cell count and the CRP level.
Both are strongly associated with infection or inflamma-
tion, similar to a low platelet count, but these signs
appeared to have no associations with AAC death in this
study. First, these findings can possibly be explained by the
skewed laboratory results that were caused by unusual
cases, such as patients receiving systemic lupus erythe-
matosus (SLE) treatment, patients receiving chemotherapy
for leukemia, and patients with a history of bone marrow
transplantation. The second set of expected but unproven
predictors are those associated with liver function, i.e.,
AST, ALT, bilirubin, PT, APTT, and INR. Although associa-
tions with poor outcomes were observed (Table 4), the
predictive powers could not be confirmed (Table 5) pri-
marily because these pieces of information were not
incorporated into the regression analyses owing to the
considerable numbers of missing values that could not be
retrieved retrospectively. Incorporating this information
would have compromised the numbers of patients available
for the analyses and thus might have introduced bias.
Notably, there is another important sign that we did not
incorporate into our current regression analyses, i.e., the
TG13 severity score.13 This score was strongly associated
with AAC death (Table 4) and increased the chance of
mortality (p < 0.001, data not shown). Although the results
are promising, they must be interpreted with caution, pri-
marily because we only examined AAC patients in inpatient
settings. The lack of outpatient cases might have caused an
underestimation of the number of low severity cases and a
consequent overestimation or underestimation of the pre-
dictive power of the severity grade.
Although several important findings were obtained in
this study, it is also subject to three limitations. First,
information related to the length of hospitalization was
not available primarily because of difficulties in retrieval
and the determination of the date of diagnosis, especially
among those with severe underlying diseases. Therefore,
the statistical analyses of the clinical and economic in-
fluences of AAC could not be assessed. Second, according
to the current clinical practices of the study hospital,
regular follow-up abdominal sonograms were not arranged
for all patients, and thus the resolution times for AAC
could not be examined. Therefore, recovery time, which
is one potential indicator of poor outcome, could not be
investigated. Finally, several important pieces of infor-
mation were left unexamined because of considerable
numbers of missing values owing to the retrospective na-
ture of the study. To complete this investigation and
strengthen the results, a prospective study design
involving more patients is desired.
AAC is broadly considered to be a mild disease among
pediatric patients and is often neglected by clinicians.
However, our study demonstrated that AAC can lead to
severe health outcomes, including death, if not treated
with caution. Additionally, in this study, we identified novel
signs (such as CRP, hepatomegaly, and anorexia) and
confirmed important risk factors (such as anemia, throm-
bocytopenia, bile sludge formation, hepatitis, and sepsis
plus hepatitis) of AAC mortality. These signs and predictors
are expected to support clinicians in making informed
clinical decisions regarding patients who require intensive
monitoring and/or interventions to reduce the possibility of
severe health outcomes of AAC.
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